AOD-9604 (also known as Anti-Obesity Drug 9604, hGH fragment 176-191) is a growth-hormone fragment studied for fat metabolism. This page covers what the published research does — and does not — establish about it in relation to fat loss and weight management.
AOD-9604 is researched for Fat metabolism — which is why it appears in discussions of fat loss and weight management.
Research status: Human trials for obesity did not meet primary endpoints; further research ongoing.
How AOD-9604 is thought to work
AOD-9604 is a modified fragment of the C-terminus of human growth hormone (residues 176-191). It was designed to stimulate fat metabolism (lipolysis) without the growth-promoting or blood-sugar effects of full-length growth hormone.
What it does not establish
Weight-loss efficacy was not established in clinical trials. Not an approved therapy.
Nothing on this page is a recommendation to use AOD-9604, and Selpho publishes no dosing, reconstitution or sourcing information. Read how we decide what goes in the library.
Other peptides researched for Fat Loss
A GLP-1 receptor agonist approved for type 2 diabetes and weight management.
A dual GIP/GLP-1 receptor agonist approved for diabetes and weight management.
An investigational triple GIP/GLP-1/glucagon agonist studied for weight loss.
A long-acting amylin analog studied for appetite and weight, often with semaglutide.
An investigational GLP-1/glucagon dual agonist studied for weight and liver health.
Frequently asked questions
Human trials for obesity did not meet primary endpoints; further research ongoing. Research relevant to this area covers fat metabolism. That is a description of where the research points, not evidence that it will work for you — and Selpho does not provide dosing or medical advice.
Human trials for obesity did not meet primary endpoints; further research ongoing.
Weight-loss efficacy was not established in clinical trials. Not an approved therapy. Always speak to a licensed healthcare professional before considering any peptide.
Fat metabolism and body composition, with some interest in cartilage and joint research.
Human obesity trials did not meet their primary weight-loss endpoints, so efficacy for weight loss is not established.
Is AOD-9604 right for your situation?
Describe your goals and the free Peptide Advisor will match them against the research — no signup, no sales pitch.
Ask the Advisor — freeThis page is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.